270 related articles for article (PubMed ID: 19416258)
1. Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy.
Gostynski A; Deviaene FC; Pasmooij AM; Pas HH; Jonkman MF
Br J Dermatol; 2009 Aug; 161(2):444-7. PubMed ID: 19416258
[TBL] [Abstract][Full Text] [Related]
2. Successful therapeutic transplantation of revertant skin in epidermolysis bullosa.
Gostyński A; Pasmooij AM; Jonkman MF
J Am Acad Dermatol; 2014 Jan; 70(1):98-101. PubMed ID: 24176523
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of cell line LSV5 that retains the altered adhesive properties of human junctional epidermolysis bullosa keratinocytes.
Miquel C; Gagnoux-Palacios L; Durand-Clement M; Marinkovich P; Ortonne JP; Meneguzzi G
Exp Cell Res; 1996 May; 224(2):279-90. PubMed ID: 8612705
[TBL] [Abstract][Full Text] [Related]
4. Keratinocytes from junctional epidermolysis bullosa do adhere and migrate on the basement membrane protein nicein through alpha 3 beta 1 integrin.
Verrando P; Lissitzky JC; Sarret Y; Winberg JO; Gedde-Dahl T; Schmitt D; Bruckner-Tuderman L
Lab Invest; 1994 Oct; 71(4):567-74. PubMed ID: 7967512
[TBL] [Abstract][Full Text] [Related]
5. Treatment of two patients with Herlitz junctional epidermolysis bullosa with artificial skin bioequivalents.
Jiang QJ; Izakovic J; Zenker M; Fartasch M; Meneguzzi G; Rascher W; Schneider H
J Pediatr; 2002 Oct; 141(4):553-9. PubMed ID: 12378197
[TBL] [Abstract][Full Text] [Related]
6. Autosomal dominant junctional epidermolysis bullosa.
Almaani N; Liu L; Dopping-Hepenstal PJ; Lovell PA; Lai-Cheong JE; Graham RM; Mellerio JE; McGrath JA
Br J Dermatol; 2009 May; 160(5):1094-7. PubMed ID: 19120338
[TBL] [Abstract][Full Text] [Related]
7. Generalized atrophic benign epidermolysis bullosa.
Darling TN; Bauer JW; Hintner H; Yancey KB
Adv Dermatol; 1997; 13():87-119; discussion 120. PubMed ID: 9551142
[TBL] [Abstract][Full Text] [Related]
8. Non-herlitz junctional epidermolysis bullosa.
Yancey KB; Hintner H
Dermatol Clin; 2010 Jan; 28(1):67-77. PubMed ID: 19945618
[TBL] [Abstract][Full Text] [Related]
9. Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia.
Vailly J; Gagnoux-Palacios L; Dell'Ambra E; Roméro C; Pinola M; Zambruno G; De Luca M; Ortonne JP; Meneguzzi G
Gene Ther; 1998 Oct; 5(10):1322-32. PubMed ID: 9930337
[TBL] [Abstract][Full Text] [Related]
10. Herlitz junctional epidermolysis bullosa.
Laimer M; Lanschuetzer CM; Diem A; Bauer JW
Dermatol Clin; 2010 Jan; 28(1):55-60. PubMed ID: 19945616
[TBL] [Abstract][Full Text] [Related]
11. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations.
Pasmooij AM; Nijenhuis M; Brander R; Jonkman MF
J Invest Dermatol; 2012 May; 132(5):1374-83. PubMed ID: 22318390
[TBL] [Abstract][Full Text] [Related]
12. Pigmentation and melanocyte supply to the epidermis depend on type XVII collagen.
Gostyński A; Pasmooij AM; Del Rio M; Diercks GF; Pas HH; Jonkman MF
Exp Dermatol; 2014 Feb; 23(2):130-2. PubMed ID: 24330315
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa.
Mallipeddi R; Keane FM; McGrath JA; Mayou BJ; Eady RA
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):521-6. PubMed ID: 15324385
[TBL] [Abstract][Full Text] [Related]
14. Localized and generalized forms of blistering in junctional epidermolysis bullosa due to COL17A1 mutations in the Netherlands.
Pasmooij AM; Pas HH; Jansen GH; Lemmink HH; Jonkman MF
Br J Dermatol; 2007 May; 156(5):861-70. PubMed ID: 17263807
[TBL] [Abstract][Full Text] [Related]
15. Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.
Pasmooij AM; Pas HH; Bolling MC; Jonkman MF
J Clin Invest; 2007 May; 117(5):1240-8. PubMed ID: 17476356
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.
Umegaki-Arao N; Pasmooij AM; Itoh M; Cerise JE; Guo Z; Levy B; Gostyński A; Rothman LR; Jonkman MF; Christiano AM
Sci Transl Med; 2014 Nov; 6(264):264ra164. PubMed ID: 25429057
[TBL] [Abstract][Full Text] [Related]
17. BP180 gene delivery in junctional epidermolysis bullosa.
Seitz CS; Giudice GJ; Balding SD; Marinkovich MP; Khavari PA
Gene Ther; 1999 Jan; 6(1):42-7. PubMed ID: 10341874
[TBL] [Abstract][Full Text] [Related]
18. The alpha-3 polypeptide chain of laminin 5: insight into wound healing responses from the study of genodermatoses.
Hamill KJ; McLean WH
Clin Exp Dermatol; 2005 Jul; 30(4):398-404. PubMed ID: 15953081
[TBL] [Abstract][Full Text] [Related]
19. Treatment decision-making for patients with the Herlitz subtype of junctional epidermolysis bullosa.
Yan EG; Paris JJ; Ahluwalia J; Lane AT; Bruckner AL
J Perinatol; 2007 May; 27(5):307-11. PubMed ID: 17363907
[TBL] [Abstract][Full Text] [Related]
20. Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa.
Dellambra E; Pellegrini G; Guerra L; Ferrari G; Zambruno G; Mavilio F; De Luca M
Hum Gene Ther; 2000 Nov; 11(16):2283-7. PubMed ID: 11084687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
